首页> 外国专利> VTvaf17-Act1-Cas9 GENE-THERAPEUTIC DNA VECTOR BASED ON VTvaf17 GENE-THERAPEUTIC DNA VECTOR CARRYING TARGET Cas9 GENE FOR HETEROLOGOUS EXPRESSION OF THIS TARGET GENE IN PLANT CELLS DURING GENOME EDITING OF PLANTS, METHOD OF PRODUCING AND USING GENE-THERAPEUTIC DNA VECTOR, STRAIN OF ESCHERICHIA COLI SCS110-AF/VTvaf17-Act1-Cas9 CARRYING GENE-THERAPEUTIC DNA VECTOR, METHOD FOR PREPARING THEREOF, METHOD FOR INDUSTRIAL PRODUCTION OF GENE-THERAPEUTIC DNA VECTOR

VTvaf17-Act1-Cas9 GENE-THERAPEUTIC DNA VECTOR BASED ON VTvaf17 GENE-THERAPEUTIC DNA VECTOR CARRYING TARGET Cas9 GENE FOR HETEROLOGOUS EXPRESSION OF THIS TARGET GENE IN PLANT CELLS DURING GENOME EDITING OF PLANTS, METHOD OF PRODUCING AND USING GENE-THERAPEUTIC DNA VECTOR, STRAIN OF ESCHERICHIA COLI SCS110-AF/VTvaf17-Act1-Cas9 CARRYING GENE-THERAPEUTIC DNA VECTOR, METHOD FOR PREPARING THEREOF, METHOD FOR INDUSTRIAL PRODUCTION OF GENE-THERAPEUTIC DNA VECTOR

机译:基于携带靶标Cas9基因的VTvaf17基因-治疗性DNA矢量的VTvaf17-Act1-Cas9基因-治疗性DNA矢量,用于在植物的基因编辑,基因编码,生产方法和制备过程中,在植物细胞中该靶基因的异源表达携带基因-治疗性DNA矢量的埃希氏大肠杆菌CSS110-AF / VTvaf17-Act1-Cas9的合成,制备方法,工业生产基因-治疗性DNA矢量的方法

摘要

FIELD: biotechnology; medicine; agriculture.;SUBSTANCE: invention relates to genetic engineering and can be used in biotechnology, medicine and agriculture to create plant varieties, including transgenic plants. Invention is a VTvaf17-Act1-Cas9 genetherapeutic DNA vector based on the VTvaf17 gene-vector DNA vector carrying the target Cas9 gene for heterologous expression of the target gene in plant cells during genome editing of plants, wherein the VTvaf17-Act1-Cas9 gene-therapeutic DNA vector has nucleotide sequence SEQ ID No. 1.;EFFECT: invention can be used in genome editing of a gene in plant cells.;8 cl, 7 dwg, 9 ex
机译:领域:生物技术;药物;农业:本发明涉及基因工程,可用于生物技术,医学和农业中以产生植物变种,包括转基因植物。本发明是基于VTvaf17-Act1-Cas9基因治疗性DNA载体,其基于携带靶Cas9基因的VTvaf17基因-载体DNA载体,用于在植物基因组编辑期间在植物细胞中异源表达靶基因,其中VTvaf17-Act1-Cas9基因-治疗性DNA载体的核苷酸序列为SEQ ID No.1;作用:本发明可用于植物细胞中基因的基因组编辑; 8 cl,7 dwg,9 ex

著录项

  • 公开/公告号RU2715314C1

    专利类型

  • 公开/公告日2020-02-26

    原文格式PDF

  • 申请/专利权人 CELL AND GENE THERAPY LTD;

    申请/专利号RU20190102156

  • 发明设计人 SAVELIEVA NATALIA (AT);

    申请日2019-01-25

  • 分类号C12N15;C12N15/12;C12N1/21;C12N15/70;

  • 国家 RU

  • 入库时间 2022-08-21 11:02:36

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号